Mastering TMS: The MagVenture Accelerator Training Path for Canadian Clinicians
With rTMS showing remission rates of 30-35% in patients with medically refractory depression, the difference between clinical success and stalled…
With rTMS showing remission rates of 30-35% in patients with medically refractory depression, the difference between clinical success and stalled…
How much of a respiratory therapist’s specialized time is lost to the manual labour of managing high-pressure gas cylinders? In busy Canadian ICUs…
Can your current ICU fleet maintain the same level of clinical precision during a high-risk intra-hospital transport as it does at the bedside? For…
With the CSCN EMG Examination scheduled for May 23, 2026, the pressure to transition from theoretical knowledge to clinical mastery is mounting for…
With the Canadian neuromodulation market projected to reach C$296.8 million by 2030, the shift toward non-invasive therapies like rTMS is no longer a…
The most resilient supply chain for inhaled nitric oxide (iNO) is the one that doesn’t exist at all. For years, Canadian clinical teams have balanced…
Discover how the BeyondAir LungFit PH iNO system is revolutionizing Canadian respiratory care by generating unlimited inhaled nitric oxide from…
Important Update: MGC Diagnostics Transitions to Direct Sales in Canada To our valued customers. Effective May 1, 2026, MGC Diagnostics...
Join us for MagVenture’s Accelerator Training Program! Dates: October 21-22 | Location: Farum, Denmark MagVenture Accelerator Training Program fast-tracks clinicians’...
Join us for MagVenture’s Accelerator Training Program! Dates: May 6-8 | Location: MagVenture Headquarters, Denmark This is an intensive, hands-on...
© [2020 All Rights Reserved] — Novus Medical Inc.